In the last trading session, 1.25 million Mereo Biopharma Group Plc ADR (NASDAQ:MREO) shares changed hands as the company’s beta touched 0.82. With the company’s per share price at $2.67 changed hands at -$0.05 or -1.84% during last session, the market valuation stood at $373.96M. MREO’s last price was a discount, traded about -63.3% off its 52-week high of $4.36. The share price had its 52-week low at $0.92, which suggests the last value was 65.54% up since then. When we look at Mereo Biopharma Group Plc ADR’s average trading volume, we note the 3-month average coming to 1.73 million.

Mereo Biopharma Group Plc ADR (NASDAQ:MREO) trade information

Instantly MREO was in red as seen at the end of in last trading. With action -15.77%, the performance over the past five days has been red. The drop to weekly highs of 3.18 subtracted -1.84% to the stock’s daily price. The company’s shares are showing year-to-date upside of 15.58%, with the 5-day performance at -15.77% in the red. However, in the 30-day time frame, Mereo Biopharma Group Plc ADR (NASDAQ:MREO) is -14.97% down.

Mereo Biopharma Group Plc ADR (MREO) estimates and forecasts

Data shows that the Mereo Biopharma Group Plc ADR share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 106.98% over the past 6 months, a 110.00% in annual growth rate that is considerably higher than the industry average of 13.00%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 41.78%. The 2024 estimates are for Mereo Biopharma Group Plc ADR earnings to increase by 68.75%.

MREO Dividends

Mereo Biopharma Group Plc ADR is expected to release its next quarterly earnings report in May.